Elanix Biotechnologies AG buy krebskrebs
Start price
17.05.20
/
50%
€1.44
Target price
04.11.21
€0.50
Performance (%)
-85.42%
End price
05.11.21
€0.21
Summary
This prediction ended on 05.11.21 with a price of €0.21. Massive losses of -85.42% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Elanix Biotechnologies AG | - | - | - | - |
iShares Core DAX® | 1.195% | 2.111% | 17.166% | 16.919% |
iShares Nasdaq 100 | 3.220% | -1.375% | 22.801% | 33.740% |
iShares Nikkei 225® | 1.858% | 0.888% | 10.064% | -0.682% |
iShares S&P 500 | 2.168% | 0.612% | 22.739% | 38.274% |
Comments by krebskrebs for this prediction
In the thread Elanix Biotechnologies AG diskutieren
Buy mit Kursziel 0,5
In the thread Trading Elanix Biotechnologies AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten